Creative Planning Buys 3,251 Shares of Doximity, Inc. (NASDAQ:DOCS)

Creative Planning increased its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 20.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 19,433 shares of the company’s stock after buying an additional 3,251 shares during the quarter. Creative Planning’s holdings in Doximity were worth $544,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Apella Capital LLC raised its holdings in Doximity by 19.4% during the first quarter. Apella Capital LLC now owns 46,843 shares of the company’s stock worth $1,238,000 after acquiring an additional 7,626 shares in the last quarter. RFG Advisory LLC boosted its holdings in shares of Doximity by 6.0% during the first quarter. RFG Advisory LLC now owns 24,726 shares of the company’s stock worth $665,000 after acquiring an additional 1,401 shares during the period. Oak Thistle LLC bought a new stake in Doximity in the 1st quarter valued at $323,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Doximity in the first quarter valued at about $583,000. Finally, State of Michigan Retirement System grew its stake in shares of Doximity by 6.0% in the first quarter. State of Michigan Retirement System now owns 30,000 shares of the company’s stock valued at $807,000 after acquiring an additional 1,700 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Insider Buying and Selling

In other news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the completion of the sale, the chief financial officer now owns 309,627 shares in the company, valued at $10,836,945. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, CFO Anna Bryson sold 30,000 shares of the firm’s stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $35.00, for a total value of $1,050,000.00. Following the transaction, the chief financial officer now owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kira Scherer Wampler sold 2,500 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $28.18, for a total value of $70,450.00. Following the sale, the director now directly owns 10,258 shares of the company’s stock, valued at $289,070.44. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 35,451 shares of company stock valued at $1,201,018. 39.40% of the stock is owned by company insiders.

Doximity Stock Performance

Shares of DOCS opened at $41.95 on Tuesday. The firm has a market cap of $7.78 billion, a PE ratio of 58.26, a price-to-earnings-growth ratio of 5.29 and a beta of 1.29. Doximity, Inc. has a 52-week low of $19.89 and a 52-week high of $44.88. The business’s 50 day moving average price is $38.24 and its two-hundred day moving average price is $30.81.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.06. Doximity had a net margin of 32.53% and a return on equity of 19.26%. The firm had revenue of $126.68 million during the quarter, compared to the consensus estimate of $119.88 million. Research analysts predict that Doximity, Inc. will post 0.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Wells Fargo & Company lowered shares of Doximity from an “equal weight” rating to an “underweight” rating and decreased their target price for the stock from $27.00 to $19.00 in a research report on Thursday, July 18th. Needham & Company LLC upgraded Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research report on Friday, August 9th. Evercore ISI increased their target price on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Canaccord Genuity Group increased their price objective on shares of Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Finally, Bank of America boosted their target price on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a research report on Monday, October 7th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Doximity has a consensus rating of “Hold” and an average price target of $34.42.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.